CN101249209A - Nosebleed stopping powder and method of preparing the same - Google Patents
Nosebleed stopping powder and method of preparing the same Download PDFInfo
- Publication number
- CN101249209A CN101249209A CNA2008100839228A CN200810083922A CN101249209A CN 101249209 A CN101249209 A CN 101249209A CN A2008100839228 A CNA2008100839228 A CN A2008100839228A CN 200810083922 A CN200810083922 A CN 200810083922A CN 101249209 A CN101249209 A CN 101249209A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- nosebleed
- preparation
- achyranthis bidentatae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses styptic powders and a preparation method thereof. The styptic powders have the components by weight parts as follows: radix achyranthis bidentatae is 15 to 25 parts, pinelliae tuber is 15 to 25 parts, dwarf lilyturf turber is 5 to 10 parts, angelica is 15 to 20 parts, Salvia miltiorrhiza is 15 to 20 parts, herbaceous peony roots are 15 to 20 parts, aconite is 15 to 20 parts, agrimony is 5 to 10 parts, scutellaria is 5 to 10 parts, radix rehmanniae is 5 to 10 parts, and glycyrrhiza is 5 to 10 parts. The styptic powders have the preparation method that the raw ingredients are rinsed and washed, and are taken out and air-dried; the radix achyranthis bidentatae, the pinelliae tuber and the angelica are respectively put in an earthen pot and stir-fried into charcoals, are crushed into dead small by a muller respectively, and are screened; the aconite, the agrimony, the scutellaria and the radix rehmanniae which are air-dried are respectively delivered to a section cutter to be cut into flakelet; then the processed raw ingredients and the other raw ingredients are delivered into the muller to be crushed into the dead small and screened. The styptic powders has the advantages of easily obtained raw ingredients, low price, quick hemostasis, thoroughness, no toxic and side effects, and good curative effect.
Description
Technical field
The present invention relates to contain medicinal preparation that derives from plant material and preparation method thereof, particularly a kind of nosebleed of ending is loose and preparation method thereof.
Background technology
Epistaxis is a kind of disease disease of stubbornness, and the medicine that doctor trained in Western medicine Shang Wu treats preferably, Chinese medicine xijiao Dihuang Tang are the better medicaments for the treatment of epistaxis at present, and effective percentage can reach 85%, but its spice is worth costliness.
How treatment to the epistaxis disease at present ends medicines such as injection with agrimonine, blood coagulation, though effective at that time, curative effect is general, and not lasting, just has repeatedly after a few days; The also useful various charcoal classes of Chinese medicine are fried in shallow oil soup and taken as Chinese mugwort charcoal, secondary charcoal, Rhizoma Imperatae charcoal, Radix Rubiae, ancestor's charcoal, Pollen Typhae carbon, and are only effective in cure to the hyporrhea patient, but not obvious to severe case's curative effect.
Because human body endogenous fire and the caused epistaxis of extraneous collision are recurrent, China and most countries generally all adopt to take medicine or inject and reach the hemostatic purpose, and these medicine compositions are many, and complex process costs an arm and a leg, and haemostatic effect is slow.
Another kind method is to adopt absorbent cotton to stop up or to pinch nose be that blood does not flow out with pointing, this method is simple, will blow outward with bigger air-flow but will clear up hematocele when blood after stopping, this makes, and to obtain very short wound of multiple time hemorrhage the as easy as rolling off a log second time.In addition, in the hemostatic process, the patient can only breathe by the oral cavity, and is promptly unhygienic inconvenient again.
Epistaxis is the common multiple disease of serious harm human health, and the epistaxis patient surpasses 100,000,000 people in the world at present, and China has also surpassed ten million, and the trend that increases is year by year arranged.If the long-term epistaxis of patient can cause dizzy margins of eyelids, feels sick, appetite descends, depressed, the myasthenia of limbs of lethargy, even also can cause anemia, have a strong impact on health, especially even more serious to intelligence, the body development influence of youngsters and children.
Both at home and abroad to the primary disease Drug therapy, run into following thorny problem at present: glycerol is smeared with dropping liquid profit nose class curative effect of medication low, with producing its dependency, side effect occurs for a long time; External application hemostasis class mode, only a bit effect at short notice, because of its Zhi Qibiao, so Zhi Qinei not is can not Zhi Qigen; Antipyretic and antidotal type medicine for oral administration such as berberine, with producing antibody, biological activity reduces for a long time, and dosage increases, and impels microangiopathies.Though also have the method and the medicine of some other treatment epistaxis, effect is not fairly obvious, can not effect a radical cure epistaxis.
Summary of the invention
The invention provides a kind of nosebleed of ending looses and preparation method thereof, on the basis of traditional medicine in conjunction with clinical experience for many years, adopting modern processing method to make with extra care forms, for the treatment hemorrhagic disease provides curative effect fast, effect is obvious, hemostasis is thorough, not repeatedly, and the Chinese medicine preparation of no side effects and preparation method thereof.
For solving the problems of the technologies described above, the invention provides a kind of nosebleed of ending and loose, it is characterized in that, the ratio of weight and number of various compositions is: Radix Achyranthis Bidentatae 15-25 part, Rhizoma Pinelliae Preparata 15-25 part, Radix Ophiopogonis 5-10 part, Radix Angelicae Sinensis 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Radix Paeoniae Alba 15-20 part, Radix Aconiti Lateralis Preparata 15-20 part, Herba Agrimoniae 5-10 part, Radix Scutellariae 5-10 part, Radix Rehmanniae 5-10 part, Radix Glycyrrhizae 5-10 part.
Described the loose ratio of weight and number of various compositions of nosebleed that ends can also be Radix Achyranthis Bidentatae 20-25 part, Rhizoma Pinelliae Preparata 20-25 part, Radix Ophiopogonis 8-10 part, Radix Angelicae Sinensis 15-18 part, Radix Salviae Miltiorrhizae 15-18 part, Radix Paeoniae Alba 15-18 part, Radix Aconiti Lateralis Preparata 15-18 part, Herba Agrimoniae 5-8 part, Radix Scutellariae 5-8 part, Radix Rehmanniae 5-8 part, Radix Glycyrrhizae 5-8 part.
Described the loose ratio of weight and number of various compositions of nosebleed that ends also can be Radix Achyranthis Bidentatae 15-20 part, Rhizoma Pinelliae Preparata 15-20 part, Radix Ophiopogonis 5-8 part, Radix Angelicae Sinensis 18-20 part, Radix Salviae Miltiorrhizae 18-20 part, Radix Paeoniae Alba 18-20 part, Radix Aconiti Lateralis Preparata 18-20 part, Herba Agrimoniae 8-10 part, Radix Scutellariae 8-10 part, Radix Rehmanniae 8-10 part, Radix Glycyrrhizae 8-10 part.
The diffusing Rhizoma Imperatae 5-10 part that may further include according to ratio of weight and number of described only nosebleed, Radix Glehniae 5-10 part.
The described diffusing preparation method of nosebleed of ending may further comprise the steps: with described raw material water brush, wash clean, pull out and dry; Radix Achyranthis Bidentatae, Rhizoma Pinelliae Preparata, Radix Angelicae Sinensis are put into marmite respectively fry into charcoal, respectively it is ground into smalls, sieve with pulverizer; Radix Aconiti Lateralis Preparata after will drying, Herba Agrimoniae, Radix Scutellariae, Radix Rehmanniae are sent into respectively and are cut into flakelet in the microtome, again the raw material of above-mentioned processing and all the other raw materials are sent into pulverizer and are ground into smalls, sieve.
The used sieve that sieves can be the 80-110 order.
The time of stirring in blender can be 10~15 minutes.
The described diffusing preparation method of nosebleed of ending can comprise the step that adopts ultraviolet radiation to carry out disinfection to mixed smalls.
Only the diffusing processing technology of nosebleed is simple in the present invention, and cost is low.The described only haemostatic effect that nosebleed is diffusing is obvious, and only nosebleed is diffusing as long as blow spray the present invention when nosebleed, makes medicine attached to the petechia, just can reach anastalsis.The present invention ends that nosebleed looses can enhancing human body immunity power, reduces, alleviates the effect of epistaxis complication, is a kind of epistaxis therapeutic agent evident in efficacy.
The specific embodiment
The present invention only contains abundant nutrition in the diffusing medicament of nosebleed, and plant protein content height in its raw material is rich in several amino acids and trace element.
The present invention ends the diffusing raw material of nosebleed and contains following composition:
Radix Achyranthis Bidentatae: the abnormal smells from the patient picric acid is flat, cures mainly cold-damp flaccidity syndrome and arthralgia syndrome, spasm of the limbs, the gonalgia unable to flex and stretch the extremities, and by vim and vigour, the fire of getting mildewed in warm conditions is mashed, and clothes of a specified duration are made light of one's life by commiting suicide anti-old, are longer than liver and kidney tonifying, strong waist knee joint and the effect of invigorating blood circulation, drawing the little row of blood;
Rhizoma Pinelliae Preparata: have, the function of stopping nausea and vomiting by lowering the adverse flow of QI, eliminating stagnation expectorant;
Radix Ophiopogonis: sweet, little hardship is slightly cold, YIN nourishing and the production of body fluid promoting, and lung moistening clears away heart-fire.Be used for dryness of the lung dry cough, the chronic consumptive disease cough, Tianjin wound is thirsty, vexed insomnia, interior-heat is quenched one's thirst, the dryness of the intestine constipation;
Radix Angelicae Sinensis: contain basic lactone (ligusiilide), n-butene acyl lactone (n-butylidene phthalide), ferulic acid, nicotinic acid, sucrose and several amino acids, and sesquiterpenoids etc.Enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores." Treatise on Febrile Disease with Notes ": the arteries and veins person house of blood, all blood all belongs to the heart, all persons of promoting blood circulation must be first reinforcing the heart benefit blood, so Zhang Zhongjing control brothers faint cold, the thready pulse being about to disappear person, with the hardship temperature of Radix Angelicae Sinensis to help painstaking effort;
Radix Salviae Miltiorrhizae: the root master contains diterpene quinones pigment, TANSHINONES (tanshinone) I, II A, II B, cryptotanshinone (cryptotanshinone), iso tanshinone (isotanshinones) I, II, different cryptotanshinone (lsocryptotanshinone), miltirone (miltirone), Methyl tanshinoate (methyltanshinonate), hydroxyl Tanshinone I I A (hydroxytanshinone), dihydrotanshinone I (dihydrotanshinone I), neotanshinone A, second, the third, methylene tanshinquinone (methylenetanshinquinone) and carnosol (salviol).In addition report closes ferruginal (ferruginol), Δ 1-miltirone (Δ l-dehydromiltirone), Δ l-Tanshinone I I A (Δ l-dehydrotanshinone IIA), danshenxinkun fourth (danshenxinkun D) and 1,2. dihydro Radix Salviae Miltiorrhizae quinone etc.Except that diterpene quinone, still contain protocatechualdehyde (protocatechuic aldehyde), cupreol and D (+) β-(3,4 one dihydroxy phenyl) lactic acid (being danshensu, saivianic acid A), and the carboxylic acid compound that contracts (salvianolic acids) A, E etc.1. the reparation that promotes tissue and regeneration promote reparation and the regeneration organized, and necrotic myocardium is removed soon; Fibroblast differentiation, collagen fiber form more obvious; Granulation forms comparative maturity.Local congestion alleviates, blood circulation improves, and healing time shortens.2. suppress hyperplasia the fibroblast of hyperplasia is had inhibitory action.
The Radix Paeoniae Alba: contain paeoniflorin, paeonol, paeoniflorin, benzoic acid is about 1.07%, volatile oil, fatty oil, resin, tannin, sugar, starch, phlegmatic temperament, protein, cupreol and triterpenes.Sichuan product person contains a kind of acidic materials in addition, and staphylococcus aureus is had inhibitory action." not Lu ": clear and coherent blood vessels, slow in, dispelling malignant blood, expelling extravasated blood, the gas that anhydrates, sharp bladder, intestine and small intestine, subduing inflammation, row cold and heat when (controlling), attacked by pestiferous factors stomachache, lumbago.
Radix Aconiti Lateralis Preparata: blood vessel dilating is arranged, and increasing blood flow improves the blood circulation effect.Radix Aconiti Lateralis Preparata injection or demethylcoclaurine intravenous injection have obvious blood vessel dilating effect, all can make the big heart output of anesthesia, coronary artery blood flow.Cerebral blood flow and femoral artery blood flow obviously increase, and vascular resistance reduces, and this effect can be blocked by propranolol.Radix Aconiti Lateralis Preparata boosts and hypotensive effect is arranged the influence of blood pressure is existing, and is relevant with its ingredient.Studies have shown that, demethylcoclaurine is the blood pressure lowering effective ingredient, has the dual function of excited beta receptor and blocking-up al receptor, and the methyl chloride dopamine is a receptor stimulating agent, Salsolinol all has excitation to beta receptor and a receptor, and the two is the boosting effective ingredient.
Herba Agrimoniae: agrimonine tannin that Herba Agrimoniae includes and vitamin K all are local hemostatic active ingredients.
Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, the cough due to lung-heat, the hyperpyrexia excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus.
Radix Rehmanniae: contain catalpol, rehmanin (Rehmanin), vitamin A sample material and polysaccharide: stachyose (Stachyose) is about 48.3%, D-galactose, D-fructose, D-glucamine (D-glvcosamine), sucrose, Raffinose, verbascose, D-mannose etc.In addition, still contain amino acids: lysine, histidine, arginine, serine, glutamic acid, valine, leucine, tyrosine, phenylalanine etc., phosphoric acid about 1.3%.Mannitol (Mannite) C 6 H 8 (Oh) 6, irony etc.
Rhizoma Imperatae: contain volume sucrose, glucose, a small amount of fructose, xylose and citric acid, oxalic acid, malic acid etc., contain 21% starch again.Isolate Anemonin (Anemonin), mannitol, Coixol (Coixol) and arundoin (Arvndoin0.1%), seal to Mao Su (Cylin-drin 0.001%) etc. from this product.
Radix Glehniae: be used for the few expectorant of dry cough that lung-heat yin-deficiency causes, the consumptive disease spitting of blood of coughing, the dry pharynx hoarseness, with same usefulness Radix Ophiopogonis, controlling scorching impairment of YIN, cough all diseases of spitting blood.
Radix Glycyrrhizae: Radix Glycyrrhizae property is flat, and sweet in the mouth has detoxifcation, eliminates the phlegm, pain relieving, spasmolytic be so that pharmacological action such as anticancer.On the traditional Chinese medical science, the Radix Glycyrrhizae invigorating the spleen and replenishing QI is grown and to be coughed lung moistening, and the emergency detoxifcation is in harmonious proportion hundred medicines.Western modern medicine haircut is existing, and the Radix Glycyrrhizae agent has the function of antiinflammatory and the reflection of resistance attitude, and mainly as demulcent, relieving cough eliminates the phlegm, treatment pharyngalgia laryngitis; Radix Glycyrrhizae or enoxolone have the effect of desoxycortone class, and chronic adrenocortical hypofunction is had good efficacy; Glycyrrhiza preparation can promote stomach mucus to form and secretion, prolongs the epithelial cell life-span, and anti-inflammatory activity is arranged, and is usually used in the treatment of chronic ulcer and duodenal ulcer; The flavone of Radix Glycyrrhizae has antiinflammatory, spasmolytic and antiacid effect.
That each Chinese medicine of distinguishing the flavor of share effect is auxilliary mutually, has reached the desirable curative effect that can quick-acting haemostatic powder wound surface is recovered as early as possible.
The present invention ends the diffusing ratio of weight and number of nosebleed and is generally:
22 parts of Radix Achyranthis Bidentataes, 22 parts of Rhizoma Pinelliae Preparata, 8 parts of Radix Ophiopogonis, 18 parts of Radix Angelicae Sinensis, 18 parts of Radix Salviae Miltiorrhizaes, 18 parts of the Radix Paeoniae Albas, 18 parts of Radix Aconiti Lateralis Preparatas, 8 parts of Herba Agrimoniaes, 8 parts of Radix Scutellariaes, 8 parts of Radix Rehmanniae, 8 parts in Radix Glycyrrhizae.
Perhaps: 18 parts of Radix Achyranthis Bidentataes, 18 parts of Rhizoma Pinelliae Preparata, 5 parts of Radix Ophiopogonis, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Herba Agrimoniaes, 10 parts of Radix Scutellariaes, 10 parts of Radix Rehmanniae, 10 parts in Radix Glycyrrhizae.
Can also be 22 parts of Radix Achyranthis Bidentataes, 22 parts of Rhizoma Pinelliae Preparata, 8 parts of Radix Ophiopogonis, 18 parts of Radix Angelicae Sinensis, 18 parts of Radix Salviae Miltiorrhizaes, 18 parts of the Radix Paeoniae Albas, 18 parts of Radix Aconiti Lateralis Preparatas, 8 parts of Herba Agrimoniaes, 8 parts of Radix Scutellariaes, 8 parts of Radix Rehmanniae, 8 parts in Radix Glycyrrhizae, 5 parts of Rhizoma Imperataes, 5 parts of Radix Glehniaes.
Also can be 18 parts of Radix Achyranthis Bidentataes, 18 parts of Rhizoma Pinelliae Preparata, 5 parts of Radix Ophiopogonis, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Herba Agrimoniaes, 10 parts of Radix Scutellariaes, 10 parts of Radix Rehmanniae, 10 parts in Radix Glycyrrhizae, 10 parts of Rhizoma Imperataes, 10 parts of Radix Glehniaes.
Embodiment 1: Mrs Wang, 28 years old.During each menstrual onset, all follow nasal bleeding, amount of bleeding is bigger.Use the present invention to end nosebleed and loose three times, menstrual period, the nasal bleeding symptom was promptly eliminated, and did not have recurrence so far.
Embodiment 2: Mr. Zhao, 63 years old.Because of nasal bleeding incessantly in hospitalize a couple of days, do not heal.Allow it that cotton balls is taken out, and the nasal cavity clot is scooped up.Suck the above-mentioned Chinese medicinal powder that has prepared at once, nose bleeding is upright to be ended.The back continuation is used the present invention to end and is defeated in battle and loose 10, and is fine through feedback effects.
Embodiment 3: Miss Li, and 22 years old, annual when dry in autumn, patient morning, frequent nasal bleeding when wash one's face night sucked the nosebleed of ending that the present invention prepares and looses, and nose bleeding is upright to end one-time cure.Confirm not have later recurrence through following up a case by regular visits to.
Embodiment 4: Mrs Bai, 52 years old.After getting up morning one day, the bilateral nasal bleeding can not stop blooding immediately with cotton balls compressing, after its cotton balls is taken out, sucks the present invention's divided powder of only being defeated in battle immediately, and nose bleeding is upright to be ended, and uses the back to cure five times.Through following up a case by regular visits to, patient's reflection does not have recurrence later, and is respond well.
Embodiment 5: Mr. Li, 12 years old, the tertion of junior middle school.When playing basketball and people collision cause the nasal cavity traumatic hemorrhage.Use packing 1 hour invalid.Only be defeated in battle divided powder once with the present invention, and blood flow promptly ends, and use once 2 day subsequently every day, do not have recurrence later again.
Embodiment 6: Mr. He, and 33 years old, the nasal bleeding when patient gos out morning sucked the present invention's divided powder of only being defeated in battle, and nose bleeding is upright to end one-time cure.Confirm not have later recurrence through following up a case by regular visits to.
Claims (8)
1. one kind is ended nosebleed and looses, and it is characterized in that the ratio of weight and number of various compositions is: Radix Achyranthis Bidentatae 15-25 part, Rhizoma Pinelliae Preparata 15-25 part, Radix Ophiopogonis 5-10 part, Radix Angelicae Sinensis 15-20 part, Radix Salviae Miltiorrhizae 15-20 part, Radix Paeoniae Alba 15-20 part, Radix Aconiti Lateralis Preparata 15-20 part, Herba Agrimoniae 5-10 part, Radix Scutellariae 5-10 part, Radix Rehmanniae 5-10 part, Radix Glycyrrhizae 5-10 part.
2. loose according to the described nosebleed of ending of claim 1, it is characterized in that the ratio of weight and number of various compositions is: Radix Achyranthis Bidentatae 20-25 part, Rhizoma Pinelliae Preparata 20-25 part, Radix Ophiopogonis 8-10 part, Radix Angelicae Sinensis 15-18 part, Radix Salviae Miltiorrhizae 15-18 part, Radix Paeoniae Alba 15-18 part, Radix Aconiti Lateralis Preparata 15-18 part, Herba Agrimoniae 5-8 part, Radix Scutellariae 5-8 part, Radix Rehmanniae 5-8 part, Radix Glycyrrhizae 5-8 part.
3. loose according to the described nosebleed of ending of claim 1, it is characterized in that the ratio of weight and number of various compositions is: Radix Achyranthis Bidentatae 15-20 part, Rhizoma Pinelliae Preparata 15-20 part, Radix Ophiopogonis 5-8 part, Radix Angelicae Sinensis 18-20 part, Radix Salviae Miltiorrhizae 18-20 part, Radix Paeoniae Alba 18-20 part, Radix Aconiti Lateralis Preparata 18-20 part, Herba Agrimoniae 8-10 part, Radix Scutellariae 8-10 part, Radix Rehmanniae 8-10 part, Radix Glycyrrhizae 8-10 part.
4. loose according to the described only nosebleed of claim 1, it is characterized in that, the diffusing Rhizoma Imperatae 5-10 part that further comprises according to ratio of weight and number of described only nosebleed, Radix Glehniae 5-10 part.
One kind according among the claim 1-4 any one describedly end the preparation method that nosebleed is loose, it is characterized in that, may further comprise the steps:, pull out and dry described raw material water brush, wash clean; Radix Achyranthis Bidentatae, Rhizoma Pinelliae Preparata, Radix Angelicae Sinensis are put into marmite respectively fry into charcoal, respectively it is ground into smalls, sieve with pulverizer; Radix Aconiti Lateralis Preparata after will drying, Herba Agrimoniae, Radix Scutellariae, Radix Rehmanniae are sent into respectively and are cut into flakelet in the microtome, again the raw material of above-mentioned processing and all the other raw materials are sent into pulverizer and are ground into smalls, sieve.
6. the diffusing preparation method of nosebleed of ending according to claim 5 is characterized in that the used sieve that sieves is the 80-110 order.
7. the diffusing preparation method of nosebleed of ending according to claim 5 is characterized in that the time of stirring is 10~15 minutes in blender.
8. the diffusing preparation method of nosebleed of ending according to claim 5 is characterized in that described method further comprises the step that adopts ultraviolet radiation to carry out disinfection to mixed smalls.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100839228A CN101249209B (en) | 2008-03-07 | 2008-03-07 | Nosebleed stopping powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100839228A CN101249209B (en) | 2008-03-07 | 2008-03-07 | Nosebleed stopping powder |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101249209A true CN101249209A (en) | 2008-08-27 |
CN101249209B CN101249209B (en) | 2010-12-29 |
Family
ID=39952919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100839228A Expired - Fee Related CN101249209B (en) | 2008-03-07 | 2008-03-07 | Nosebleed stopping powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101249209B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101791382A (en) * | 2010-04-09 | 2010-08-04 | 郑济 | Chinese herbal medicine combination for treating nasal bleeding |
CN105641532A (en) * | 2016-03-16 | 2016-06-08 | 曲思廉 | Traditional Chinese medicine for treating epistaxis |
CN108452171A (en) * | 2018-05-04 | 2018-08-28 | 遵义医学院 | A kind of Chinese medicine of prevention nosebleed epistaxis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060673C (en) * | 1998-05-11 | 2001-01-17 | 于万海 | 'Binuting' medicine for treating hemorrhinia |
CN1583078A (en) * | 2004-05-24 | 2005-02-23 | 谢国云 | Prescription of |
CN100471518C (en) * | 2004-06-18 | 2009-03-25 | 王人杰 | Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel |
-
2008
- 2008-03-07 CN CN2008100839228A patent/CN101249209B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101791382A (en) * | 2010-04-09 | 2010-08-04 | 郑济 | Chinese herbal medicine combination for treating nasal bleeding |
CN101791382B (en) * | 2010-04-09 | 2012-08-29 | 郑济 | Chinese herbal medicine combination for treating nasal bleeding |
CN105641532A (en) * | 2016-03-16 | 2016-06-08 | 曲思廉 | Traditional Chinese medicine for treating epistaxis |
CN108452171A (en) * | 2018-05-04 | 2018-08-28 | 遵义医学院 | A kind of Chinese medicine of prevention nosebleed epistaxis |
Also Published As
Publication number | Publication date |
---|---|
CN101249209B (en) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102847063B (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency blood stasis type diabetic feet, and its preparation method | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
CN104127685A (en) | Application of external-use plaster composition in preparation of drug used for treating skin injury | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN101249209B (en) | Nosebleed stopping powder | |
CN108619473A (en) | A kind of Chinese medicine fuming-lotion for treating diabete peripheral herve pathology | |
CN104398997B (en) | It is a kind of for Chinese medicine composition of scleroderma circumscriptum and preparation method thereof | |
CN104940513A (en) | Pharmaceutical composition for treating menopause syndrome | |
CN100509008C (en) | Shutongfang for killing pain and preparation and use thereof | |
CN110384785A (en) | A kind of external application Chinese medicine medical fluid and preparation method thereof for treating virus flu | |
CN104225344A (en) | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof | |
CN101322816B (en) | Chinese medicinal composition for treating scapulohumeral periarthritis | |
CN104127686A (en) | External-use plaster composition and preparation method thereof | |
CN107334963A (en) | A kind of medicament for treating nephrotic syndrome and preparation method thereof | |
CN102406769A (en) | Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof | |
CN105213749A (en) | Be used for the treatment of osteoporotic preparation and method for making | |
CN105169013A (en) | Prescription for treating thromboangiitis obliterans | |
CN104645109B (en) | A kind of Chinese medicine preparation for treating liver purple plague purpura disease and preparation method thereof | |
CN104784666A (en) | Traditional Chinese medicine ointment for orthopedic nursing | |
CN105056073A (en) | Traditional Chinese medicine preparation for treating arrhythmia and preparing method thereof | |
CN104771601A (en) | Combination agent for improving blood viscosity and platelet aggregation | |
CN104800687A (en) | Traditional Chinese medicine preparation for treating infantile malnutrition and preparation method thereof | |
CN109966393A (en) | It treats hypertension and hypertension causes Chinese materia medica preparation of apoplexy and preparation method thereof | |
CN104887862A (en) | TCM (traditional Chinese medicine) preparation for coronary heart disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101229 Termination date: 20110307 |